⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Bashar SaadMD

Endocrinology · San Dimas, CA 91773

NPI: 1275611360

Share:

9

🟢 Low

Risk Flags

Opioid + benzodiazepine co-prescriber

Risk indicators are statistical patterns, not allegations. Learn more

20,925

Total Claims

$8.7M

Drug Cost

2,421

Beneficiaries

$3,576

Cost/Patient

Risk Score Breakdown 9/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid + benzodiazepine combo+8

Score components are additive. Read full methodology

Peer Comparison vs. 6,382 Endocrinology providers

-9%

Cost per patient vs peers

$3,576 vs $3,933 avg

-3%

Brand preference vs peers

49.8% vs 51.2% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

0.1%

Opioid Rate

29

Opioid Claims

$850

Opioid Cost

Long-Acting Rate

Brand vs Generic

50% generic

Brand: 9,800 claims · $8.3M

Generic: 9,889 claims · $275K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Empagliflozin1,541$1.2M
Semaglutide951$1.1M
Dulaglutide880$1.1M
Semaglutide334$398K
Tirzepatide287$380K
Dapagliflozin Propanediol497$367K
Insulin Lispro411$349K
Denosumab196$315K
Insulin Glargine,hum.Rec.Anlog573$314K
Insulin Aspart373$295K
Sitagliptin Phosphate302$233K
Insulin Glargine,hum.Rec.Anlog210$168K
Insulin Degludec214$122K
Insulin Glargine,hum.Rec.Anlog177$91K
Insulin Lispro101$88K

Prescribing Profile

113

Unique Drugs

$2.2M

IRA Negotiated Drugs

$3.1M

GLP-1 Drugs

9.0

Anomaly Score

Patient Profile

72

Avg Age

61%

Female

1.88

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data